Home › Funds › SAMLYN CAPITAL, LLC › INSM
SAMLYN CAPITAL, LLC position in INSM
INSMED INC · Health Care
SAMLYN CAPITAL, LLC reported holding 732,568 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$78.1M, representing 1.29% of its reported portfolio and ranking #24 among its reported holdings. SAMLYN CAPITAL, LLC has disclosed INSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SAMLYN CAPITAL, LLC's INSM position evolved
SAMLYN CAPITAL, LLC first disclosed a stake in INSM in Q3 2023 at 1,381,057 shares (US$34.9M). The position peaked in Q2 2026 at 732,568 shares, worth US$78.1M. Across 10 filings, SAMLYN CAPITAL, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 732,568 shares valued at US$78.1M — an increase of 315,363 shares quarter over quarter.. Notable position changes include a 54% trim in Q1 2024 (shares rose 147% over the following quarter), a 41% trim in Q3 2024 (shares fell 5% over the following quarter), a 76% increase in Q2 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.38M | $34.87M | New |
| Q4 2023 | 1.29M | $39.88M | Reduce |
| Q1 2024 | 587.63K | $15.94M | Reduce |
| Q2 2024 | 359.25K | $24.07M | Reduce |
| Q3 2024 | 211.50K | $15.44M | Reduce |
| Q4 2024 | 159.06K | $10.98M | Reduce |
| Q3 2025 | 292.64K | $42.14M | New |
| Q4 2025 | 369.57K | $64.32M | Add |
| Q1 2026 | 417.20K | $68.22M | Add |
| Q2 2026 | 732.57K | $78.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $937.84M · Q2 2026
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $647.88M · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Artisan Partners Limited Partnership 5.44M sh · $580.20M · Q2 2026
- RTW INVESTMENTS, LP 4.84M sh · $516.35M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- Qube Research & Technologies Ltd 1.68M sh · $179.37M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.63M sh · $173.74M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $170.59M · Q2 2026
- Bellevue Group AG 1.39M sh · $148.57M · Q2 2026
More on SAMLYN CAPITAL, LLC
FAQ
How long has SAMLYN CAPITAL, LLC held INSM?
SAMLYN CAPITAL, LLC has disclosed INSM holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is SAMLYN CAPITAL, LLC's current position in INSM?
As of Q2 2026, SAMLYN CAPITAL, LLC holds 732.57K shares of INSM (INSMED INC), valued at $78.11M, representing 1.29% of its reported portfolio and ranking #24.
Has SAMLYN CAPITAL, LLC been buying or selling INSM?
In the latest 13F filing (Q2 2026), SAMLYN CAPITAL, LLC increased its position in INSM. The position peaked in Q2 2026 at 732.57K shares.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.